BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10160338)

  • 1. Medicare and Medicaid programs; hospital standard for potentially HIV infectious blood and blood products--HCFA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47423-34. PubMed ID: 10160338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare and Medicaid programs; hospital conditions of participation: laboratory services. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2007 Aug; 72(164):48562-74. PubMed ID: 17886393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare and Medicaid programs; hospital conditions of participation: laboratory services. Final rule.
    Centers for Medicare & Medicaid Services, HHS
    Fed Regist; 2008 Jun; 73(125):36469-71. PubMed ID: 18677830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare and Medicaid programs; Medicare, Medicaid, and Clinical Laboratories Improvement Act (CLIA) patient confidentiality rules--PHS and HCFA. Final rule.
    Fed Regist; 1988 Dec; 53(232):48645-8. PubMed ID: 10302929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare and Medicaid programs; payment for the cost of malpractice insurance--HCFA. Confirmation of final rule.
    Fed Regist; 1987 Mar; 52(59):9833-63. PubMed ID: 10301431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologics products; establishment registration and product listing for manufacturers of human blood and blood products; amendment to exempt certain transfusion services from registration--FDA. Final rule.
    Fed Regist; 1984 Aug; 49(171):34448-51. PubMed ID: 10299643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare and Medicaid programs; surety bond requirements for home health agencies--HCFA. Final rule.
    Fed Regist; 1998 Jun; 63(104):29648-56. PubMed ID: 10179864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirements for testing human blood donors for evidence of infection due to communicable disease agents. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Jun; 66(112):31146-65. PubMed ID: 11725786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare and Medicaid programs; surety bond requirements for home health agencies--HCFA. Final rule.
    Fed Regist; 1998 Jul; 63(147):41170-1. PubMed ID: 10181719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare and Medicaid programs; program integrity--HCFA. Final rule.
    Fed Regist; 1986 Sep; 51(189):34786-8. PubMed ID: 10301243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare and Medicaid programs; hospital conditions of participation: anesthesia services. Health Care Financing Administration (HCFA), HHS. Final rule.
    Fed Regist; 2001 Jan; 66(12):4674-87. PubMed ID: 11503774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare and Medicaid programs; organ procurement organizations and organ procurement protocols--HCFA. Final rule.
    Fed Regist; 1988 Mar; 53(40):6526-51. PubMed ID: 10302202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare and Medicaid programs; surety bond and capitalization requirements for home health agencies--HCFA. Final rule with comment period.
    Fed Regist; 1998 Jan; 63(2):292-355. PubMed ID: 10176838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare and Medicaid programs; programs of all-inclusive care for the elderly (PACE); program revisions. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2006 Dec; 71(236):71243-337. PubMed ID: 17171853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicare and Medicaid program; withholding the federal share of payments to recover Medicare or Medicaid overpayments--HCFA. Final rule.
    Fed Regist; 1985 May; 50(91):19684-90. PubMed ID: 10300095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare and Medicaid programs; conditions of participation for hospitals--HCFA. Final regulations.
    Fed Regist; 1986 Jun; 51(116):22010-52. PubMed ID: 10300760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare and Medicaid programs; quarterly listing of program issuances; fourth quarter 1996--HCFA. Notice.
    Fed Regist; 1997 May; 62(91):25957-9. PubMed ID: 10167529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare and Medicaid programs; physicians' referrals to health care entities with which they have financial relationships. Health Care Financing Administration (HCFA), HHS. Final rule with comment period.
    Fed Regist; 2001 Jan; 66(3):856-965. PubMed ID: 11503745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.